Clinical trial
Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
NCT00492401 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00492401 |
|---|---|
| Title | Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia |
| Official title | Phase II Study of Decitabine in Acute Myeloid Leukemia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16, 16)(p13, Adult Acute Myeloid Leukemia With t(8 and 3 more |
| Intervention type | Drug, Genetic, Other |
| Interventions | decitabine, laboratory biomarker analysis, pharmacological study, high performance liquid chromatography, microarray analysis, RNA analysis, mass spectrometry, DNA methylation analysis, matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| Enrollment | 55 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Oct 1, 2014 |
| First posted | Jun 27, 2007 |
| Last update posted | Jun 27, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: